Do-Youn Oh

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Do-Youn Oh

Sep 5, 2024, 19:32 | Insight

Francisco Esteva: HER2-targeted therapies are being explored for various other solid tumors

Francisco Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill Hospital,…

Jul 25, 2024, 07:47 | Insight

HER2-targeted therapies beyond breast cancer

Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared a post on X about a…

Jul 25, 2024, 01:39 | Insight

An update on the development of HER2-targeted therapies

Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared on X: "HER2-targeted therapies…

Jul 23, 2024, 08:25 | Blog

Paolo Tarantino: HER2: a remarkable story of precision oncology

Paolo Tarantino shared on X: "HER2: a remarkable story of precision oncology. Check this wonderful Nature…

Jul 3, 2024, 05:47 | Societies

Keynote lecture on liver cancer by Stephen L Chan

Lorenza Rimassa, Associate Professor of Medical Oncology at HUNIMED, shared on X: "Ready for the…

Jun 18, 2024, 07:07 | Insight

Tislelizumab plus chemotherapy in advanced gastric/GEJ adenocarcinoma

Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X: "Tislelizumab plus chemotherapy vs…

All: 6 Posts: 1 - 100